Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lenka Munoz

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry|October 26, 2013
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituentsChristoph Eibl, Isabelle Tomassoli, Lenka Munoz, et al.
Bioorganic & Medicinal Chemistry|October 23, 2013
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifsChristoph Eibl, Lenka Munoz, Isabelle Tomassoli, et al.
Analytical Biochemistry|February 24, 2010
Fluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinaseLenka Munoz, Roland Selig, Yiu To Yeung, et al.
European Journal of Pharmacology|March 16, 2010
Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscleLenka Munoz, Emma E Ramsay, Melanie Manetsch, et al.
RSC Medicinal Chemistry|July 14, 2025
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibitionAngus J Saxton, Jayden Sterling, Michael P Hamilton, et al.
International Journal of Molecular Sciences|April 30, 2021
DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem CellsBrianna Chen, Dylan McCuaig-Walton, Sean Tan, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting AgentsRamzi H Abbassi, Ariadna Recasens, Dinesh C Indurthi, et al.
Bioorganic & Medicinal Chemistry|November 8, 2018
Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1AQingqing Zhou, Tristan A Reekie, Ramzi H Abbassi, et al.
Medchemcomm|August 16, 2018
Determination and reduction of translocator protein (TSPO) ligand rs6971 discriminationRenee Sokias, Eryn L Werry, Sook W Chua, et al.
European Journal of Medicinal Chemistry|March 21, 2015
Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammationLenka Munoz, Madeline E Kavanagh, Athena F Phoa, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|October 26, 2013
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor (nAChR) ligands. Part 1: the influence of different hydrogen bond acceptor systems on alkyl and (hetero)aryl substituentsChristoph Eibl, Isabelle Tomassoli, Lenka Munoz, et al.
Bioorganic & Medicinal Chemistry|October 23, 2013
The 3,7-diazabicyclo[3.3.1]nonane scaffold for subtype selective nicotinic acetylcholine receptor ligands. Part 2: carboxamide derivatives with different spacer motifsChristoph Eibl, Lenka Munoz, Isabelle Tomassoli, et al.
Analytical Biochemistry|February 24, 2010
Fluorescence polarization binding assay to develop inhibitors of inactive p38alpha mitogen-activated protein kinaseLenka Munoz, Roland Selig, Yiu To Yeung, et al.
European Journal of Pharmacology|March 16, 2010
Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscleLenka Munoz, Emma E Ramsay, Melanie Manetsch, et al.
RSC Medicinal Chemistry|July 14, 2025
Exploration of hydrazine-based small molecules as metal chelators for KDM4 inhibitionAngus J Saxton, Jayden Sterling, Michael P Hamilton, et al.
International Journal of Molecular Sciences|April 30, 2021
DYRK1A Negatively Regulates CDK5-SOX2 Pathway and Self-Renewal of Glioblastoma Stem CellsBrianna Chen, Dylan McCuaig-Walton, Sean Tan, et al.
ACS Pharmacology & Translational Science|April 8, 2020
Lower Tubulin Expression in Glioblastoma Stem Cells Attenuates Efficacy of Microtubule-Targeting AgentsRamzi H Abbassi, Ariadna Recasens, Dinesh C Indurthi, et al.
Bioorganic & Medicinal Chemistry|November 8, 2018
Synthesis and in vitro evaluation of diverse heterocyclic diphenolic compounds as inhibitors of DYRK1AQingqing Zhou, Tristan A Reekie, Ramzi H Abbassi, et al.
Medchemcomm|August 16, 2018
Determination and reduction of translocator protein (TSPO) ligand rs6971 discriminationRenee Sokias, Eryn L Werry, Sook W Chua, et al.
European Journal of Medicinal Chemistry|March 21, 2015
Optimisation of LRRK2 inhibitors and assessment of functional efficacy in cell-based models of neuroinflammationLenka Munoz, Madeline E Kavanagh, Athena F Phoa, et al.
Pageof 4